235 related articles for article (PubMed ID: 18077173)
1. Synthesis and biological evaluation of pyrroloiminoquinone derivatives.
Passarella D; Belinghieri F; Scarpellini M; Pratesi G; Zunino F; Gia OM; Via LD; Santoro G; Danieli B
Bioorg Med Chem; 2008 Mar; 16(5):2431-8. PubMed ID: 18077173
[TBL] [Abstract][Full Text] [Related]
2. Novel tetra-acridine derivatives as dual inhibitors of topoisomerase II and the human proteasome.
Vispé S; Vandenberghe I; Robin M; Annereau JP; Créancier L; Pique V; Galy JP; Kruczynski A; Barret JM; Bailly C
Biochem Pharmacol; 2007 Jun; 73(12):1863-72. PubMed ID: 17391647
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of rotenoid derivatives with cytotoxic and topoisomerase II inhibitory activities.
Sangthong S; Krusong K; Ngamrojanavanich N; Vilaivan T; Puthong S; Chandchawan S; Muangsin N
Bioorg Med Chem Lett; 2011 Aug; 21(16):4813-8. PubMed ID: 21741833
[TBL] [Abstract][Full Text] [Related]
4. 2-Thienyl-4-furyl-6-aryl pyridine derivatives: synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study.
Thapa P; Karki R; Thapa U; Jahng Y; Jung MJ; Nam JM; Na Y; Kwon Y; Lee ES
Bioorg Med Chem; 2010 Jan; 18(1):377-86. PubMed ID: 19939682
[TBL] [Abstract][Full Text] [Related]
5. Novel carbamate derivatives of 4-beta-amino-4'-O-demethyl-4-desoxypodophyllotoxin as inhibitors of topoisomerase II: synthesis and biological evaluation.
Duca M; Arimondo PB; Léonce S; Pierré A; Pfeiffer B; Monneret C; Dauzonne D
Org Biomol Chem; 2005 Mar; 3(6):1074-80. PubMed ID: 15750651
[TBL] [Abstract][Full Text] [Related]
6. Solid phase combinatorial synthesis of benzothiazoles and evaluation of topoisomerase II inhibitory activity.
Choi SJ; Park HJ; Lee SK; Kim SW; Han G; Choo HY
Bioorg Med Chem; 2006 Feb; 14(4):1229-35. PubMed ID: 16242334
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and topoisomerase poisoning activity of A-ring and E-ring substituted luotonin A derivatives.
Nacro K; Zha CC; Guzzo PR; Jason Herr R; Peace D; Friedrich TD
Bioorg Med Chem; 2007 Jun; 15(12):4237-46. PubMed ID: 17418582
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of novel isoellipticine derivatives and salts.
Miller CM; O'Sullivan EC; Devine KJ; McCarthy FO
Org Biomol Chem; 2012 Oct; 10(39):7912-21. PubMed ID: 22940706
[TBL] [Abstract][Full Text] [Related]
9. Antitumor agents. Part 230: C4'-esters of GL-331 as cytotoxic agents and DNA topoisomerase II inhibitors.
Han S; Xiao Z; Bastow KF; Lee KH
Bioorg Med Chem Lett; 2004 Jun; 14(11):2979-82. PubMed ID: 15125972
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antitumor activity of novel benzimidazole-5-carboxylic acid derivatives and their transition metal complexes as topoisomerease II inhibitors.
Galal SA; Hegab KH; Hashem AM; Youssef NS
Eur J Med Chem; 2010 Dec; 45(12):5685-91. PubMed ID: 20884089
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of 6-chloroisoquinoline-5,8-diones and pyrido[3,4-b]phenazine-5,12-diones and evaluation of their cytotoxicity and DNA topoisomerase II inhibitory activity.
Kim JS; Rhee HK; Park HJ; Lee IK; Lee SK; Suh ME; Lee HJ; Ryu CK; Choo HY
Bioorg Med Chem; 2007 Jan; 15(1):451-7. PubMed ID: 17035025
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological evaluation of a series of fluoroquinoanthroxazines with contrasting dual mechanisms of action against topoisomerase II and G-quadruplexes.
Kim MY; Duan W; Gleason-Guzman M; Hurley LH
J Med Chem; 2003 Feb; 46(4):571-83. PubMed ID: 12570378
[TBL] [Abstract][Full Text] [Related]
13. Design of new topoisomerase II inhibitors based upon a quinobenzoxazine self-assembly model.
Zeng Q; Kwok Y; Kerwin SM; Mangold G; Hurley LH
J Med Chem; 1998 Oct; 41(22):4273-8. PubMed ID: 9784102
[TBL] [Abstract][Full Text] [Related]
14. DNA binding ellipticine analogues: synthesis, biological evaluation, and structure-activity relationships.
Ferlin MG; Marzano C; Gandin V; Dall'Acqua S; Dalla Via L
ChemMedChem; 2009 Mar; 4(3):363-77. PubMed ID: 19197924
[TBL] [Abstract][Full Text] [Related]
15. Oxiranylmethyloxy or thiiranylmethyloxy-azaxanthones and -acridone analogues as potential topoisomerase I inhibitors.
Cho HJ; Jung MJ; Kwon Y; Na Y
Bioorg Med Chem Lett; 2009 Dec; 19(23):6766-9. PubMed ID: 19836231
[TBL] [Abstract][Full Text] [Related]
16. Antitumor agents. Part 227: Studies on novel 4'-O-demethyl-epipodophyllotoxins as antitumor agents targeting topoisomerase II.
Xiao Z; Bastow KF; Vance JR; Lee KH
Bioorg Med Chem; 2004 Jun; 12(12):3339-44. PubMed ID: 15158802
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antiproliferative activity of some ellipticine-like 11H-pyrido[a]carbazole derivatives.
Ferlin MG; Gia O; Dalla Via L
ChemMedChem; 2011 Oct; 6(10):1872-83. PubMed ID: 21826796
[TBL] [Abstract][Full Text] [Related]
18. Omega-alkoxy analogues of SAHA (vorinostat) as inhibitors of HDAC: a study of chain-length and stereochemical dependence.
Hanessian S; Auzzas L; Giannini G; Marzi M; Cabri W; Barbarino M; Vesci L; Pisano C
Bioorg Med Chem Lett; 2007 Nov; 17(22):6261-5. PubMed ID: 17892933
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of distamycin analogues - new potential anticancer agents.
Drozdowska D; Rusak M; Miltyk W; Midura-Nowaczek K
Arch Pharm (Weinheim); 2009 Feb; 342(2):87-93. PubMed ID: 19173336
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antitumor characterization of pyrazolic analogues of the marine pyrroloquinoline alkaloids: wakayin and tsitsikammamines.
Legentil L; Benel L; Bertrand V; Lesur B; Delfourne E
J Med Chem; 2006 May; 49(10):2979-88. PubMed ID: 16686539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
